glp-1 drugs and high blood pressure New Research Shows May Help Reduce New weight loss medication may

10.1016/j.biochi.2011.09.008 6 AlvarezM

AOD-9604 isolates the fat cell targeting properties of growth hormone without affecting the GH/IGF-1 axis

In real practice, experienced obesity medicine providers sometimes step patients down to lower doses or extend the interval between injections after sustained goal-weight maintenance but these adjustments are clinical decisions, not patient-initiated changes

Doctors are using a regulatory gap to prescribe an unauthorized peptide Experts urge authorities to close loophole Despite Health Canada's warnings against the use of unauthorized peptides as a health and fitness shortcut, a CBC News investigation uncovered doctors using a regulatory loophole to prescribe one of the unproven products to patients

Nootropic signals (animal): Animal studies report effects on serotonin, monoamines and BDNF